Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

STREPTOMYCIN

STREPTOMYCIN In January 1944 Schatz, Bugie and Waksman1 suggested that the antibacterial agent streptomycin possessed properties which might be of use in the treatment of diseases caused by a variety of gram-negative and some gram-positive pathogens. Since September 1944 we have subjected streptomycin to rather extensive clinical investigation. Evidence is accumulating as to the effectiveness of streptomycin in the treatment of a limited number of infections and its ineffectiveness in the treatment of many others. Future observations may change some of the present concepts concerning this antibiotic agent; however, sufficient material has been studied to justify certain conclusions at this time. With few exceptions the degree of sensitivity of organisms to streptomycin as determined by in vitro studies can be used as an index of the probable effectiveness of streptomycin in the clinical field. Streptomycin has been found to be active in vitro against a variety of gram-negative and gram-positive http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

STREPTOMYCIN

NICHOLS, DONALD R.; HERRELL, WALLACE E.
JAMA , Volume 132 (4) – Sep 28, 1946
Download PDF
7 pages

Loading next page...
 
/lp/american-medical-association/streptomycin-uglGCu8aus

References (23)

Publisher
American Medical Association
Copyright
Copyright © 1946 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1946.02870390016004
Publisher site
See Article on Publisher Site

Abstract

In January 1944 Schatz, Bugie and Waksman1 suggested that the antibacterial agent streptomycin possessed properties which might be of use in the treatment of diseases caused by a variety of gram-negative and some gram-positive pathogens. Since September 1944 we have subjected streptomycin to rather extensive clinical investigation. Evidence is accumulating as to the effectiveness of streptomycin in the treatment of a limited number of infections and its ineffectiveness in the treatment of many others. Future observations may change some of the present concepts concerning this antibiotic agent; however, sufficient material has been studied to justify certain conclusions at this time. With few exceptions the degree of sensitivity of organisms to streptomycin as determined by in vitro studies can be used as an index of the probable effectiveness of streptomycin in the clinical field. Streptomycin has been found to be active in vitro against a variety of gram-negative and gram-positive

Journal

JAMA – American Medical Association

Published: Sep 28, 1946

There are no references for this article.